Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Authors

H. Gaspar

Published

August 24, 2011

Abstract

Gene therapy can restore immune and metabolic function in patients with adenosine deaminase immunodeficiency.

Supporters

Support the authors with ResearchCoin

Journal

Science Translational Medicine

Topics

DOI

10.1126/scitranslmed.3002716

Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Authors

H. Gaspar

Published

August 24, 2011

Abstract

Gene therapy can restore immune and metabolic function in patients with adenosine deaminase immunodeficiency.

Supporters

Support the authors with ResearchCoin

Journal

Science Translational Medicine

Topics

DOI

10.1126/scitranslmed.3002716

Paper

Paper

Paper

Paper

Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Abstract

Supporters

Journal

Topics

DOI

Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Abstract

Supporters

Journal

Topics

DOI